Skip to content

Sublingual Fentanyl and Procedural Burn Pain

A Randomized, Double-blind, Placebo-controlled, Cross-over Trial of Sublingual Fentanyl Spray (Subsys) and Oral Morphine for Procedural Wound Care in Adult Patients With Burn Injury Pain

Status
Terminated
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02241486
Enrollment
2
Registered
2014-09-16
Start date
2013-09-30
Completion date
2015-03-31
Last updated
2017-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn Pain

Keywords

Burn pain, Procedural pain, Sublingual fentanyl, Morphine

Brief summary

The purpose of this study is to examine the efficacy and safety of sublingual fentanyl spray (Subsys) for procedural pain (dressing changes/minor debridement) in patients with burn injury.

Detailed description

The purpose of this study is to examine the efficacy and safety of sublingual fentanyl spray (Subsys) for procedural pain (dressing changes/minor debridement) in patients with burn injury. It will be compared with a standard treatment regimen of oral morphine. The hypothesis is that the fentanyl spray will be more effective for the treatment of procedural pain in patients with burn injury.

Interventions

DRUGSublingual Fentanyl Spray

Patients with burn injuries will receive sublingual fentanyl spray (Subsys) for procedural pain (dressing changes/minor debridement).

Sponsors

Loyola University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Subject capable of giving consent * Age 18-65 * Total burn surface area greater than or equal to 5% * Opioid tolerant * BMI less than or equal to 35

Exclusion criteria

* Subjects with cognitive or psychiatric impairment that would preclude study participation or compliance with protocol * Allergy to fentanyl, morphine, naloxone * Pregnancy, intent to become pregnant or lactating * Evidence of burn injury to oral mucosa * Active illicit drug use or illicit drug abuse history

Design outcomes

Primary

MeasureTime frameDescription
Pain Relief60 minPatients suffering from burn injuries will receive sublingual fentanyl spray (Subsys) to address procedural pain (dressing changes/minor debridement). It will be compared with a standard treatment regimen of oral morphine. The hypothesis is that the fentanyl spray will be more effective for the treatment of procedural pain in patients with burn injury.

Countries

United States

Participant flow

Pre-assignment details

There are no pre-assignment details.

Participants by arm

ArmCount
Sublingual Fentanyl Spray
Examine the efficacy and safety of sublingual fentanyl spray (Subsys) for procedural pain (dressing changes/minor debridement) in patients with burn injury. Sublingual Fentanyl Spray: Patients with burn injuries will receive sublingual fentanyl spray (Subsys) for procedural pain (dressing changes/minor debridement).
2
Total2

Baseline characteristics

CharacteristicSublingual Fentanyl Spray
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
1 Participants
Age, Categorical
Between 18 and 65 years
1 Participants
Sex: Female, Male
Female
1 Participants
Sex: Female, Male
Male
1 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 2
other
Total, other adverse events
0 / 2
serious
Total, serious adverse events
0 / 2

Outcome results

Primary

Pain Relief

Patients suffering from burn injuries will receive sublingual fentanyl spray (Subsys) to address procedural pain (dressing changes/minor debridement). It will be compared with a standard treatment regimen of oral morphine. The hypothesis is that the fentanyl spray will be more effective for the treatment of procedural pain in patients with burn injury.

Time frame: 60 min

Population: No participants are included in this analysis because the trial was terminated prematurely. As a result, data to assess primary and secondary study aims are incomplete or entirely unavailable for summary or statistical comparisons.

ArmMeasureValue
Sublingual Fentanyl SprayPain Relief0

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026